-
Join 37 other subscribers
Categories
Top Posts
Blogroll
Category Archives: Research
Boston Leads the List of Top 25 U.S. Cities for NIH Funding
Not surprisingly, the biotech hubs cluster at the top. Boston leads at $1.9B, New York $1.4B, Seattle, Philadelphia and Baltimore all coming in around $900M each. Somewhat surprising is how high Boston ranks relative to San Francisco ($680M). Consolidating San Francisco, Stanford, … Continue reading
Posted in Biotech, Healthcare, Research
Tagged NIH Funding, Research and development
Leave a comment
States with the most NIH funding
Updated for fiscal year 2016: California dominates in overall funding (above), but Massachusetts, DC, and Maryland stand out in NIH funding per capita (next chart). Below, you can see more clearly how Massachusetts has the highest per capita and second … Continue reading
Posted in Research
Leave a comment
The Brain is Connected to the Immune System
A striking paper published in Nature shows that the lymphatic system is in fact connected to the brain. This has huge implications for diseases that are linked to dysfunctional immunological responses, like multiple sclerosis, Alzheimer’s, and autism. The authors were “searching … Continue reading
Posted in Research
Leave a comment
Infographic: Total and per capita NIH award funding by state
Mid-way through 2014, California currently leads the nation with $2.1 billion in National Institutes of Health (NIH) award funding, while Massachusetts and New York are ranked 2nd and 3rd, with about $1.4B each. Not surprisingly, Massachusetts — much smaller in … Continue reading
Posted in Biotech, Pharmaceutical Industry, Research
Tagged National Institutes of Health, NIH Funding
Leave a comment
More Biotech Hub Rankings
GEN (Genetic Engineering and Biotechnology News) has released their own, more comprehensive biotech hub rankings. As expected, Boston-Cambridge and the Bay Area are at the top, with San Francisco edging out Boston in most criteria. The GEN rankings include not only … Continue reading
Posted in Biotech, Innovation, Research
Tagged Biomedical Research, Biotech cluster, Boston, San Francisco
Leave a comment
Venture Funding of Biotech is VERY Concentrated… and Very Limited
Fierce Biotech has released their latest analysis of venture capital funding of biotech in the U.S. last year, broken down by metropolitan area: Source: http://www.fiercebiotech.com/story/top-15-cities-biotech-venture-funding/2014-03-06 San Francisco is back out in front, edging out Boston-Cambridge. After San Diego and Washington, funding … Continue reading
Posted in Biotech, Innovation, Research
Tagged Biomedical Research, Biotech, Boston, Cambridge, Pharmaceutical industry, San Francsico, Venture capital
Leave a comment
Product Cycles in the Pharma Industry and How to “Shorten” Them – Part 1
A few weeks ago I commented on what may be the fundamental limit on a stable Pharmaceutical industry — products have to be on the market for at least as long as it takes to replace them. Cash flow significant … Continue reading
Posted in Fixing Big Pharma Research, Management, Research
Leave a comment
Boston-Cambridge is THE Life Sciences Hub
Luke Timmerman from Xconomy has published an analysis of where the major Life Sciences companies are located. Using the criteria of having $100 million in cash and short term assets as the definition of a major firm, his analysis highlights … Continue reading
Posted in Innovation, Research
Tagged Biotech cluster, Boston, Life sciences, National Institutes of Health, San Diego, San Francisco, Venture capital, Xconomy
6 Comments
Fixing Big Pharma Research: The costs of delays need to be properly valued
For the Pharmaceutical industry, the foregone revenue created by delays in bringing a drug to market can be surprisingly high — from $50,000 to $2,000,000 per day, depending on the phase of the pipeline. Such costs are often under appreciated. … Continue reading
Posted in Management, Research
Tagged Clinical trial, Drug discovery, Pharma, Pharmaceutical industry
Leave a comment
Fixing Big Pharma Research: Introduction
Lots of articles and blog posts get written about the research productivity crisis in the pharmaceutical industry. A lot of Wall Street types argue that Pharma companies simply must spend less on R&D (Recently, yet another analyst called for a … Continue reading
MechanizedIntelligence 